RITONAVIR

RITONAVIR was reported 53956 times

RITONAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 114 0.8837
1 AIDS ENCEPHALOPATHY 34 0.5862
2 ULTRASOUND ANTENATAL SCREEN 56 0.5833
3 CLOACAL EXSTROPHY 32 0.5424
4 BLADDER AGENESIS 33 0.4459
5 BLOOD HIV RNA 19 0.3654
6 HIV ASSOCIATED NEPHROPATHY 18 0.3529
7 SUPERNUMERARY NIPPLE 25 0.3049
8 CONGENITAL NAEVUS 43 0.3028
9 GASTROINTESTINAL DISORDER CONGENITAL 32 0.3019
10 AIDS DEMENTIA COMPLEX 18 0.2951
11 HYPERCORTICOIDISM 30 0.2830
12 CSF HIV ESCAPE SYNDROME 39 0.2826
13 ALPHA 1 FOETOPROTEIN ABNORMAL 28 0.2800
14 GENITALIA EXTERNAL AMBIGUOUS 41 0.2370
15 HEMIVERTEBRA 40 0.2367
16 LIPODYSTROPHY ACQUIRED 460 0.2165
17 MECONIUM STAIN 33 0.2143
18 CAUDAL REGRESSION SYNDROME 32 0.2051
19 BONE DEMINERALISATION 215 0.2030
20 ERGOT POISONING 25 0.2000
21 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 22 0.1982
22 MITOCHONDRIAL TOXICITY 159 0.1937
23 ACOUSTIC STIMULATION TESTS ABNORMAL 29 0.1859
24 CUSHING'S SYNDROME 122 0.1755
25 CONGENITAL GENITAL MALFORMATION 27 0.1688
26 CD4 LYMPHOCYTES ABNORMAL 35 0.1667
27 IMMUNE RECONSTITUTION SYNDROME 212 0.1642
28 ULTRASOUND ANTENATAL SCREEN ABNORMAL 35 0.1591
29 TRISOMY 18 59 0.1549
30 VIROLOGIC FAILURE 809 0.1503
31 VENTRICULAR HYPOPLASIA 37 0.1480
32 TETHERED CORD SYNDROME 30 0.1357
33 ANOGENITAL DYSPLASIA 19 0.1267
34 HETEROTAXIA 21 0.1257
35 CONGENITAL ANOMALY IN OFFSPRING 16 0.1212
36 ADRENAL SUPPRESSION 97 0.1151
37 CHORDEE 16 0.1135
38 SPINE MALFORMATION 39 0.1124
39 GASTROINTESTINAL MALFORMATION 23 0.1100
40 CD4 LYMPHOCYTES DECREASED 233 0.1087
41 FOETAL CHROMOSOME ABNORMALITY 18 0.1059
42 KAPOSI'S SARCOMA 52 0.1036
43 BLOOD HIV RNA INCREASED 187 0.1030
44 CHOLESTASIS OF PREGNANCY 46 0.1000
45 UMBILICAL CORD ABNORMALITY 52 0.0987
46 MITOCHONDRIAL CYTOPATHY 42 0.0955
47 EXOMPHALOS 50 0.0931
48 OESOPHAGEAL ATRESIA 58 0.0928
49 TERATOGENICITY 28 0.0927
50 FANCONI SYNDROME ACQUIRED 162 0.0922
51 HIV VIRAEMIA 19 0.0905
52 LOW SET EARS 37 0.0900
53 LIPOHYPERTROPHY 55 0.0884
54 CONGENITAL HEART VALVE DISORDER 21 0.0882
55 BLOOD CORTISOL DECREASED 56 0.0875
56 PSYCHIATRIC DECOMPENSATION 170 0.0869
57 ACQUIRED IMMUNODEFICIENCY SYNDROME 45 0.0867
58 HYDROPS FOETALIS 53 0.0865
59 SYPHILIS 61 0.0839
60 TRISOMY 21 105 0.0833
61 ATRIOVENTRICULAR SEPTAL DEFECT 39 0.0830
62 RENAL COLIC 184 0.0813
63 VIRAL MUTATION IDENTIFIED 291 0.0789
64 CONGENITAL CHOROID PLEXUS CYST 24 0.0787
65 POLYDACTYLY 91 0.0784
66 LARYNGOMALACIA 26 0.0776
67 CONGENITAL HYDRONEPHROSIS 55 0.0769
68 ANAL ATRESIA 41 0.0768
69 PLACENTAL INFARCTION 17 0.0762
70 RENAL DYSPLASIA 29 0.0749
71 PERIVENTRICULAR LEUKOMALACIA 21 0.0742
72 RENAL TUBULAR DYSFUNCTION 41 0.0726
73 GENOTYPE DRUG RESISTANCE TEST POSITIVE 73 0.0710
74 SINGLE UMBILICAL ARTERY 26 0.0705
75 RENAL TUBULAR DISORDER 197 0.0700
76 SKULL MALFORMATION 44 0.0684
77 LIPOATROPHY 65 0.0683
78 NEURAL TUBE DEFECT 49 0.0674
79 CONGENITAL HYDROCEPHALUS 34 0.0671
80 HAEMOPHILIC ARTHROPATHY 16 0.0669
81 FANCONI SYNDROME 91 0.0643
82 FACIAL WASTING 17 0.0632
83 CONGENITAL FOOT MALFORMATION 28 0.0617
84 CENTRAL OBESITY 44 0.0595
85 MENINGOMYELOCELE 35 0.0583
86 BLOOD BILIRUBIN UNCONJUGATED INCREASED 42 0.0579
87 PSYCHOMOTOR SKILLS IMPAIRED 148 0.0564
88 CONGENITAL DIAPHRAGMATIC HERNIA 22 0.0563
89 CALCULUS URINARY 85 0.0552
90 AMYOTROPHY 21 0.0544
91 STILLBIRTH 261 0.0540
92 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 267 0.0535
93 BLIGHTED OVUM 21 0.0534
94 BRAIN STEM STROKE 26 0.0527
95 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 56 0.0518
96 SECONDARY ADRENOCORTICAL INSUFFICIENCY 77 0.0510
97 VIRAL LOAD INCREASED 196 0.0504
98 GLYCOSURIA 67 0.0496
99 CEREBRAL VENTRICLE DILATATION 56 0.0486
100 PYELOCALIECTASIS 46 0.0480
101 POLYHYDRAMNIOS 49 0.0480
102 ANAEMIA NEONATAL 23 0.0477
103 ANHEDONIA 1235 0.0469
104 ANENCEPHALY 26 0.0460
105 CONGENITAL MUSCULOSKELETAL ANOMALY 20 0.0454
106 NODULAR REGENERATIVE HYPERPLASIA 29 0.0452
107 ANKYLOGLOSSIA CONGENITAL 18 0.0448
108 DEPRESSION SUICIDAL 155 0.0447
109 DEPRESSIVE SYMPTOM 156 0.0442
110 SPINA BIFIDA 92 0.0441
111 HIV INFECTION 133 0.0441
112 PLACENTA PRAEVIA 34 0.0433
113 PULMONARY HYPOPLASIA 34 0.0431
114 BLOOD CORTICOTROPHIN DECREASED 21 0.0430
115 PREMATURE RUPTURE OF MEMBRANES 100 0.0414
116 LEFT VENTRICULAR DILATATION 21 0.0411
117 SUDDEN INFANT DEATH SYNDROME 19 0.0386
118 LIVE BIRTH 312 0.0373
119 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 123 0.0372
120 RENAL APLASIA 26 0.0370
121 HYPERBILIRUBINAEMIA 383 0.0369
122 LIMB MALFORMATION 29 0.0368
123 TEARFULNESS 157 0.0365
124 PLACENTAL INSUFFICIENCY 29 0.0361
125 HYPERBILIRUBINAEMIA NEONATAL 21 0.0361
126 PORTAL HYPERTENSION 111 0.0360
127 CLEFT LIP AND PALATE 40 0.0358
128 PORTAL HYPERTENSIVE GASTROPATHY 20 0.0355
129 PATHOGEN RESISTANCE 318 0.0349
130 LOW BIRTH WEIGHT BABY 275 0.0346
131 CYTOMEGALOVIRUS CHORIORETINITIS 67 0.0343
132 CYTOLYTIC HEPATITIS 111 0.0334
133 HODGKIN'S DISEASE 24 0.0331
134 RETINAL TOXICITY 34 0.0330
135 HEPATITIS B DNA INCREASED 22 0.0326
136 DIAPHRAGMATIC HERNIA 20 0.0323
137 TWIN PREGNANCY 27 0.0321
138 ECONOMIC PROBLEM 486 0.0320
139 ANAL CANCER 31 0.0320
140 HEPATOBILIARY DISEASE 20 0.0319
141 CUSHINGOID 102 0.0317
142 SINGLE FUNCTIONAL KIDNEY 21 0.0317
143 DYSLIPIDAEMIA 156 0.0307
144 MYCOBACTERIUM AVIUM COMPLEX INFECTION 82 0.0305
145 HYDROCELE 32 0.0300
146 CEREBRAL TOXOPLASMOSIS 28 0.0300
147 ABORTION INDUCED 280 0.0297
148 VIRAEMIA 41 0.0296
149 HYPERTRIGLYCERIDAEMIA 173 0.0295
150 FOETAL EXPOSURE DURING PREGNANCY 2398 0.0295
151 OSTEOPENIA 444 0.0292
152 CALCULUS URETERIC 21 0.0290
153 SKIN STRIAE 43 0.0289
154 TOXOPLASMOSIS 31 0.0287
155 PRURIGO 26 0.0282
156 FOETAL GROWTH RESTRICTION 171 0.0281
157 ANOGENITAL WARTS 25 0.0280
158 COARCTATION OF THE AORTA 27 0.0280
159 ENANTHEMA 16 0.0278
160 PLACENTAL DISORDER 26 0.0275
161 OPHTHALMOPLEGIA 43 0.0272
162 PREMATURE DELIVERY 429 0.0269
163 PSYCHOMOTOR RETARDATION 75 0.0267
164 CYTOGENETIC ABNORMALITY 30 0.0266
165 PREMATURE BABY 797 0.0265
166 PREMATURE LABOUR 148 0.0261
167 DRUG RESISTANCE 657 0.0256
168 HYPERLACTACIDAEMIA 68 0.0253
169 ALPHA 1 FOETOPROTEIN INCREASED 18 0.0253
170 AMNIOTIC CAVITY INFECTION 18 0.0249
171 FOETAL DEATH 127 0.0245
172 SYNDACTYLY 20 0.0241
173 HEART DISEASE CONGENITAL 84 0.0237
174 NEPHRITIS INTERSTITIAL 30 0.0237
175 INTRA-UTERINE DEATH 38 0.0237
176 OESOPHAGEAL CANDIDIASIS 93 0.0233
177 FOETAL GROWTH RETARDATION 18 0.0230
178 OSTEOMALACIA 35 0.0226
179 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 24 0.0226
180 SMALL FOR DATES BABY 112 0.0225
181 MULTIPLE-DRUG RESISTANCE 69 0.0222
182 CAESAREAN SECTION 257 0.0221
183 PNEUMOCYSTIS JIROVECI PNEUMONIA 49 0.0220
184 FOETAL HEART RATE ABNORMAL 20 0.0216
185 MYCOBACTERIAL INFECTION 37 0.0215
186 ABORTION SPONTANEOUS 855 0.0213
187 MICROCEPHALY 27 0.0210
188 OSTEOPOROSIS 865 0.0210
189 MENINGITIS CRYPTOCOCCAL 36 0.0206
190 BLOOD AMYLASE INCREASED 35 0.0204
191 FOETAL MALFORMATION 22 0.0202
192 GENE MUTATION 40 0.0202
193 VENTRICULAR SEPTAL DEFECT 114 0.0199
194 WHITE MATTER LESION 25 0.0198
195 RENAL TUBULAR ACIDOSIS 43 0.0197
196 NEPHROCALCINOSIS 23 0.0194
197 CYSTITIS NONINFECTIVE 26 0.0194
198 FAT TISSUE INCREASED 28 0.0193
199 OCULAR ICTERUS 82 0.0189
200 BLOOD LACTIC ACID INCREASED 97 0.0184
201 NORMAL NEWBORN 100 0.0184
202 BONE DENSITY DECREASED 572 0.0182
203 PREMATURE SEPARATION OF PLACENTA 28 0.0182
204 DEATH NEONATAL 25 0.0180
205 ANAEMIA OF CHRONIC DISEASE 16 0.0177
206 PATENT DUCTUS ARTERIOSUS 69 0.0174
207 CONGENITAL ANOMALY 132 0.0170
208 GENITAL HERPES 26 0.0170
209 ATYPICAL MYCOBACTERIAL INFECTION 24 0.0170
210 ECTOPIC PREGNANCY 51 0.0166
211 EXPOSURE DURING PREGNANCY 1015 0.0163
212 OSTEOPOROTIC FRACTURE 31 0.0162
213 DRUG INTERACTION 2561 0.0161
214 BONE MARROW TOXICITY 19 0.0160
215 FOETAL DISTRESS SYNDROME 34 0.0160
216 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0160
217 VARICES OESOPHAGEAL 48 0.0159
218 END STAGE RENAL DISEASE 289 0.0158
219 NEONATAL DISORDER 25 0.0158
220 ENCEPHALITIS VIRAL 19 0.0156
221 DRUG EXPOSURE DURING PREGNANCY 530 0.0156
222 PRE-ECLAMPSIA 74 0.0156
223 LIPIDS INCREASED 31 0.0153
224 VANISHING BILE DUCT SYNDROME 17 0.0152
225 MATERNAL DRUGS AFFECTING FOETUS 117 0.0152
226 HEPATITIS CHOLESTATIC 91 0.0151
227 ANAEMIA MACROCYTIC 32 0.0150
228 HYPOSPADIAS 31 0.0149
229 EYELID PTOSIS 150 0.0147
230 HYPOPHOSPHATAEMIA 106 0.0143
231 GESTATIONAL DIABETES 68 0.0143
232 CRYPTORCHISM 16 0.0142
233 NEPHROPATHY TOXIC 160 0.0142
234 OSTEONECROSIS 462 0.0141
235 HEPATOSPLENOMEGALY 36 0.0140
236 MATERNAL EXPOSURE DURING PREGNANCY 1245 0.0140
237 SEBORRHOEIC DERMATITIS 23 0.0139
238 MULTIPLE FRACTURES 226 0.0137
239 ADRENAL INSUFFICIENCY 164 0.0135
240 JAUNDICE 359 0.0133
241 OLIGOHYDRAMNIOS 44 0.0132
242 HYPERURICAEMIA 54 0.0131
243 CELL DEATH 26 0.0131
244 CACHEXIA 67 0.0130
245 ACQUIRED GENE MUTATION 17 0.0130
246 BLOOD BILIRUBIN INCREASED 346 0.0128
247 HYPERPARATHYROIDISM SECONDARY 32 0.0128
248 GLOMERULAR FILTRATION RATE ABNORMAL 18 0.0127
249 PORTAL VEIN THROMBOSIS 41 0.0127
250 HEPATITIS C 153 0.0127
251 HEPATOCELLULAR INJURY 179 0.0126
252 NEONATAL RESPIRATORY DISTRESS SYNDROME 44 0.0124
253 VENTRICULAR HYPERTROPHY 31 0.0123
254 RENAL TUBULAR NECROSIS 121 0.0123
255 PROTEINURIA 232 0.0122
256 HEPATITIS B 73 0.0121
257 OESOPHAGEAL VARICES HAEMORRHAGE 26 0.0120
258 HYPERLIPIDAEMIA 143 0.0120
259 TALIPES 37 0.0119
260 CHRONIC KIDNEY DISEASE 898 0.0118
261 BREAST DISORDER 24 0.0118
262 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 97 0.0118
263 HYDROCEPHALUS 64 0.0117
264 PREGNANCY ON CONTRACEPTIVE 17 0.0116
265 BONE LOSS 175 0.0116
266 NEPHROPATHY 108 0.0116
267 EMOTIONAL DISTRESS 1388 0.0115
268 DYSMORPHISM 27 0.0115
269 DRUG LEVEL INCREASED 189 0.0114
270 CEREBELLAR SYNDROME 25 0.0114
271 VITAMIN D DEFICIENCY 111 0.0114
272 KIDNEY FIBROSIS 19 0.0109
273 NEPHROLITHIASIS 497 0.0108
274 PREGNANCY 214 0.0107
275 PARANOIA 182 0.0105
276 HYPERCHOLESTEROLAEMIA 101 0.0105
277 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 91 0.0103
278 CYTOMEGALOVIRUS TEST POSITIVE 18 0.0101
279 HEPATORENAL SYNDROME 17 0.0101
280 CARDIAC MURMUR 87 0.0100
281 DECREASED ACTIVITY 108 0.0100
282 QUALITY OF LIFE DECREASED 134 0.0100
283 RENAL FAILURE ACUTE 423 0.0100
284 CONDUCTION DISORDER 18 0.0098
285 ATRIAL SEPTAL DEFECT 82 0.0098
286 OPPORTUNISTIC INFECTION 18 0.0097
287 HEPATOMEGALY 95 0.0097
288 INTRAVENTRICULAR HAEMORRHAGE 24 0.0096
289 JAUNDICE NEONATAL 18 0.0095
290 ALANINE AMINOTRANSFERASE ABNORMAL 20 0.0095
291 HYPERPARATHYROIDISM 19 0.0092
292 BLOOD PHOSPHORUS DECREASED 33 0.0090
293 BLOOD TRIGLYCERIDES INCREASED 159 0.0090
294 CLEFT PALATE 17 0.0088
295 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
296 HYDRONEPHROSIS 65 0.0087
297 TOOTH LOSS 179 0.0086
298 RENAL IMPAIRMENT 722 0.0086
299 HEPATITIS B REACTIVATION 27 0.0085
300 GLOMERULAR FILTRATION RATE DECREASED 104 0.0085
301 BLOOD BICARBONATE DECREASED 16 0.0084
302 BILIRUBIN CONJUGATED INCREASED 19 0.0081
303 HEPATOTOXICITY 181 0.0081
304 CHOLESTASIS 155 0.0081
305 DERMATITIS EXFOLIATIVE 40 0.0080
306 BLOOD CREATININE INCREASED 517 0.0079
307 TREATMENT NONCOMPLIANCE 432 0.0079
308 HAND FRACTURE 55 0.0078
309 PSYCHOTIC DISORDER 229 0.0077
310 PULMONARY TUBERCULOSIS 33 0.0077
311 TOXIC SKIN ERUPTION 77 0.0076
312 SKELETAL INJURY 79 0.0076
313 DILATATION VENTRICULAR 16 0.0076
314 RASH MACULO-PAPULAR 169 0.0076
315 RENAL TRANSPLANT 27 0.0075
316 GAMMA-GLUTAMYLTRANSFERASE INCREASED 165 0.0074
317 FOOT FRACTURE 140 0.0074
318 SPINAL COMPRESSION FRACTURE 61 0.0074
319 APHTHOUS STOMATITIS 17 0.0074
320 ORAL CANDIDIASIS 97 0.0074
321 GLOMERULONEPHRITIS 18 0.0073
322 POLYDIPSIA 29 0.0073
323 EOSINOPHILIA 128 0.0073
324 HEPATIC CYTOLYSIS 93 0.0073
325 HEPATITIS TOXIC 19 0.0073
326 OESOPHAGEAL ULCER 28 0.0073
327 DYSAESTHESIA 22 0.0072
328 VOLVULUS 17 0.0072
329 RENAL FAILURE 951 0.0072
330 TRANSAMINASES INCREASED 159 0.0071
331 ASPARTATE AMINOTRANSFERASE INCREASED 378 0.0071
332 ALANINE AMINOTRANSFERASE INCREASED 431 0.0070
333 DRUG LEVEL ABOVE THERAPEUTIC 32 0.0070
334 HAEMOLYTIC ANAEMIA 62 0.0069
335 DERMATITIS EXFOLIATIVE GENERALISED 24 0.0069
336 HEPATIC ENCEPHALOPATHY 64 0.0069
337 FIBROSIS 21 0.0068
338 HEPATITIS 174 0.0068
339 LIPASE INCREASED 52 0.0068
340 NYSTAGMUS 36 0.0068
341 CREATININE RENAL CLEARANCE DECREASED 27 0.0067
342 CONGESTIVE CARDIOMYOPATHY 28 0.0067
343 HEPATIC FIBROSIS 23 0.0067
344 NEPHROGENIC ANAEMIA 31 0.0067
345 SPEECH DISORDER DEVELOPMENTAL 19 0.0066
346 HEPATIC CIRRHOSIS 124 0.0066
347 PNEUMOCYSTIS JIROVECII PNEUMONIA 66 0.0066
348 DRUG LEVEL DECREASED 66 0.0065
349 STRABISMUS 19 0.0065
350 PYELONEPHRITIS 56 0.0065
351 BLOOD CREATINE PHOSPHOKINASE INCREASED 186 0.0065
352 ATRIOVENTRICULAR BLOCK FIRST DEGREE 28 0.0065
353 LACTIC ACIDOSIS 208 0.0064
354 BLOOD ALKALINE PHOSPHATASE INCREASED 159 0.0064
355 ODYNOPHAGIA 38 0.0064
356 SPLENOMEGALY 74 0.0063
357 CANDIDIASIS 25 0.0062
358 CEREBRAL ISCHAEMIA 32 0.0062
359 RASH MORBILLIFORM 17 0.0061
360 MYOSITIS 55 0.0061
361 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 23 0.0060
362 ACUTE KIDNEY INJURY 904 0.0059
363 RETINOPATHY 22 0.0059
364 BILIARY COLIC 17 0.0058
365 PROTEIN URINE PRESENT 29 0.0058
366 APLASIA PURE RED CELL 20 0.0058
367 ENCEPHALITIS 40 0.0058
368 GROWTH RETARDATION 17 0.0058
369 TIBIA FRACTURE 27 0.0058
370 HYPOMANIA 21 0.0057
371 HEPATIC FAILURE 172 0.0057
372 ANXIETY 1622 0.0057
373 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 273 0.0057
374 JAUNDICE CHOLESTATIC 20 0.0057
375 ACUTE LYMPHOCYTIC LEUKAEMIA 16 0.0056
376 HUMERUS FRACTURE 27 0.0056
377 EXERCISE TOLERANCE DECREASED 32 0.0056
378 ESCHERICHIA SEPSIS 16 0.0055
379 ABORTION 16 0.0055
380 POTENTIATING DRUG INTERACTION 18 0.0054
381 RENAL FAILURE CHRONIC 41 0.0053
382 AUTOIMMUNE HEPATITIS 37 0.0053
383 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 41 0.0053
384 FEMORAL NECK FRACTURE 27 0.0053
385 HEPATIC STEATOSIS 98 0.0053
386 GLUCOSE TOLERANCE IMPAIRED 31 0.0052
387 DIPLOPIA 136 0.0052
388 ANGINA UNSTABLE 34 0.0052
389 ANOREXIA 67 0.0052
390 LYMPHOMA 80 0.0052
391 CORONARY ARTERY STENOSIS 26 0.0052
392 HEPATOCELLULAR CARCINOMA 39 0.0051
393 ASCITES 150 0.0051
394 TORSADE DE POINTES 40 0.0051
395 MYOPATHY 44 0.0051
396 HEPATITIS ACUTE 33 0.0051
397 MACULOPATHY 18 0.0051
398 HEPATIC NECROSIS 19 0.0050
399 ACUTE HEPATIC FAILURE 68 0.0050
400 BRONCHOPNEUMONIA 17 0.0050
401 RIB FRACTURE 102 0.0050
402 PATHOLOGICAL FRACTURE 25 0.0049
403 HERPES SIMPLEX 32 0.0049
404 BLOOD LACTATE DEHYDROGENASE INCREASED 78 0.0049
405 WRIST FRACTURE 59 0.0049
406 PANCYTOPENIA 275 0.0049
407 TUBULOINTERSTITIAL NEPHRITIS 92 0.0049
408 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
409 AORTIC STENOSIS 17 0.0049
410 RENAL INJURY 144 0.0048
411 METABOLIC ACIDOSIS 155 0.0048
412 NEPHROTIC SYNDROME 33 0.0048
413 PANCREATITIS ACUTE 108 0.0048
414 ANKLE FRACTURE 74 0.0048
415 RHABDOMYOLYSIS 198 0.0047
416 LIVER FUNCTION TEST ABNORMAL 138 0.0047
417 FACE OEDEMA 80 0.0047
418 HYPOTONIA 47 0.0047
419 CLAVICLE FRACTURE 18 0.0047
420 GOITRE 19 0.0046
421 HAEMATOTOXICITY 44 0.0046
422 DRUG TOXICITY 63 0.0046
423 ACUTE MYOCARDIAL INFARCTION 135 0.0046
424 CHOLELITHIASIS 150 0.0046
425 NEUROLOGICAL SYMPTOM 26 0.0045
426 ANURIA 39 0.0045
427 LOW DENSITY LIPOPROTEIN INCREASED 35 0.0045
428 HYPERPHAGIA 18 0.0045
429 BLOOD URIC ACID INCREASED 26 0.0045
430 FEBRILE BONE MARROW APLASIA 19 0.0045
431 CYTOMEGALOVIRUS INFECTION 74 0.0044
432 RENAL PAIN 47 0.0044
433 MULTI-ORGAN FAILURE 76 0.0044
434 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 113 0.0044
435 SUBCUTANEOUS ABSCESS 21 0.0044
436 LIVER INJURY 107 0.0044
437 ENCEPHALOPATHY 107 0.0044
438 ANAEMIA 828 0.0043
439 LYMPHOEDEMA 30 0.0043
440 BLOOD CREATINE INCREASED 19 0.0043
441 CEREBRAL ATROPHY 17 0.0043
442 MAJOR DEPRESSION 31 0.0042
443 TREATMENT FAILURE 347 0.0042
444 ATRIOVENTRICULAR BLOCK COMPLETE 28 0.0042
445 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
446 GASTROINTESTINAL TOXICITY 20 0.0042
447 POLYURIA 34 0.0041
448 TOOTH INJURY 18 0.0041
449 RASH GENERALISED 107 0.0041
450 ACUTE CORONARY SYNDROME 34 0.0041
451 ILEUS PARALYTIC 18 0.0040
452 MALABSORPTION 21 0.0040
453 HAEMOLYSIS 31 0.0040
454 LIVER DISORDER 175 0.0039
455 PERIPHERAL SENSORY NEUROPATHY 23 0.0039
456 DEPRESSION 869 0.0038
457 EYELID OEDEMA 44 0.0038
458 PANCREATITIS 199 0.0038
459 AGRANULOCYTOSIS 69 0.0037
460 VENTRICULAR FIBRILLATION 41 0.0037
461 POLYNEUROPATHY 44 0.0037
462 HYPOKALAEMIA 169 0.0037
463 FAILURE TO THRIVE 19 0.0037
464 FRACTURE 69 0.0036
465 SOCIAL AVOIDANT BEHAVIOUR 21 0.0036
466 TOOTH FRACTURE 40 0.0036
467 HYPERKALAEMIA 125 0.0036
468 DYSSTASIA 104 0.0036
469 NERVOUS SYSTEM DISORDER 111 0.0036
470 TACHYPNOEA 48 0.0035
471 CHOLECYSTITIS 42 0.0035
472 EPSTEIN-BARR VIRUS INFECTION 22 0.0035
473 PROTHROMBIN TIME PROLONGED 21 0.0035
474 DRUG-INDUCED LIVER INJURY 109 0.0035
475 LYMPHOPENIA 49 0.0035
476 HAEMATURIA 118 0.0034
477 TUMOUR LYSIS SYNDROME 30 0.0034
478 LYMPHADENOPATHY 120 0.0034
479 PARKINSONISM 33 0.0034
480 HEPATIC FUNCTION ABNORMAL 126 0.0034
481 ELECTROCARDIOGRAM QT PROLONGED 121 0.0034
482 COMPRESSION FRACTURE 18 0.0034
483 HYPERGLYCAEMIA 122 0.0033
484 HAEMODIALYSIS 28 0.0033
485 RENAL DISORDER 155 0.0033
486 MENINGITIS 22 0.0033
487 ARTERIOSCLEROSIS 31 0.0033
488 RALES 19 0.0033
489 ACIDOSIS 25 0.0033
490 PARTIAL SEIZURES 17 0.0032
491 PULMONARY HYPERTENSION 67 0.0032
492 SQUAMOUS CELL CARCINOMA 30 0.0032
493 ERYSIPELAS 16 0.0032
494 ARTERIOSCLEROSIS CORONARY ARTERY 21 0.0032
495 SINUS TACHYCARDIA 45 0.0032
496 SUICIDAL IDEATION 289 0.0032
497 TRICUSPID VALVE INCOMPETENCE 25 0.0031
498 BEHAVIOUR DISORDER 17 0.0031
499 EMBOLISM 26 0.0031
500 HERPES VIRUS INFECTION 18 0.0031
501 NEUTROPENIC SEPSIS 22 0.0031
502 ACUTE RESPIRATORY DISTRESS SYNDROME 54 0.0031
503 PURPURA 27 0.0030
504 SPINAL FRACTURE 61 0.0030
505 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
506 UVEITIS 41 0.0030
507 HYPERTHERMIA 23 0.0030
508 GASTRIC ULCER 57 0.0030
509 THROMBOCYTOPENIA 335 0.0030
510 HYPERTHYROIDISM 43 0.0030
511 ANAL ABSCESS 16 0.0030
512 SCHIZOPHRENIA 36 0.0030
513 ERECTILE DYSFUNCTION 76 0.0030
514 IMMUNOSUPPRESSION 26 0.0029
515 PNEUMONIA BACTERIAL 27 0.0029
516 CORONARY ARTERY DISEASE 89 0.0029
517 TOXICITY TO VARIOUS AGENTS 495 0.0029
518 PSEUDOMONAS INFECTION 25 0.0029
519 NEUROTOXICITY 51 0.0029
520 HYPOVOLAEMIA 17 0.0029
521 HYPONATRAEMIA 163 0.0029
522 DIALYSIS 41 0.0029
523 COAGULOPATHY 48 0.0029
524 DIABETES MELLITUS 219 0.0029
525 ORAL DISORDER 21 0.0029
526 HYPOTHERMIA 29 0.0029
527 MALNUTRITION 32 0.0029
528 ACUTE PULMONARY OEDEMA 16 0.0028
529 POST-TRAUMATIC STRESS DISORDER 19 0.0028
530 STEVENS-JOHNSON SYNDROME 63 0.0028
531 ENTERITIS 18 0.0028
532 DRUG SCREEN POSITIVE 22 0.0028
533 BLOOD IRON DECREASED 33 0.0028
534 ATAXIA 33 0.0028
535 RENAL CYST 22 0.0028
536 ELECTROLYTE IMBALANCE 32 0.0028
537 BONE DISORDER 50 0.0027
538 GASTROENTERITIS 40 0.0027
539 MITRAL VALVE INCOMPETENCE 31 0.0027
540 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
541 IRON DEFICIENCY ANAEMIA 25 0.0027
542 MATERNAL EXPOSURE BEFORE PREGNANCY 18 0.0026
543 EYE MOVEMENT DISORDER 18 0.0026
544 HEPATIC ENZYME INCREASED 177 0.0026
545 DRUG ERUPTION 46 0.0026
546 FOLLICULITIS 27 0.0026
547 ERYTHEMA MULTIFORME 24 0.0026
548 APPENDICITIS 24 0.0026
549 STATUS EPILEPTICUS 29 0.0026
550 PAIN 1573 0.0026
551 DISSEMINATED INTRAVASCULAR COAGULATION 36 0.0026
552 DEVELOPMENTAL DELAY 23 0.0025
553 RESPIRATORY DISTRESS 70 0.0025
554 NEUROPATHY PERIPHERAL 241 0.0025
555 BRONCHIECTASIS 17 0.0025
556 BLOOD CHOLESTEROL INCREASED 117 0.0025
557 GENERAL PHYSICAL CONDITION ABNORMAL 17 0.0025
558 SPINAL OSTEOARTHRITIS 22 0.0025
559 PYREXIA 844 0.0024
560 CARDIOMEGALY 30 0.0024
561 SEPTIC SHOCK 106 0.0024
562 MYOCLONUS 29 0.0024
563 CANDIDA INFECTION 41 0.0024
564 GENERALISED OEDEMA 30 0.0024
565 HEMIPLEGIA 20 0.0024
566 SEROTONIN SYNDROME 46 0.0024
567 COMA 114 0.0024
568 BIPOLAR DISORDER 26 0.0024
569 LUNG INFILTRATION 21 0.0024
570 BRAIN OEDEMA 30 0.0024
571 COVID-19 PNEUMONIA 28 0.0024
572 DIFFUSE LARGE B-CELL LYMPHOMA 18 0.0023
573 BLOOD UREA INCREASED 39 0.0023
574 MENTAL DISORDER 100 0.0023
575 NEUTROPENIA 312 0.0023
576 MYOCARDIAL ISCHAEMIA 26 0.0023
577 ABNORMAL DREAMS 63 0.0023
578 SUDDEN DEATH 24 0.0023
579 GENERAL PHYSICAL HEALTH DETERIORATION 261 0.0023
580 HEMIPARESIS 38 0.0022
581 LEUKOPENIA 112 0.0022
582 LOWER LIMB FRACTURE 43 0.0022
583 DERMATITIS BULLOUS 16 0.0022
584 BRONCHOPULMONARY ASPERGILLOSIS 17 0.0022
585 HYPERCALCAEMIA 27 0.0022
586 CENTRAL NERVOUS SYSTEM LESION 30 0.0022
587 GRAND MAL CONVULSION 20 0.0022
588 IMPAIRED WORK ABILITY 46 0.0021
589 MUCOSAL INFLAMMATION 56 0.0021
590 SHOCK 49 0.0021
591 EPILEPSY 65 0.0021
592 MOBILITY DECREASED 152 0.0021
593 CORONARY ARTERY OCCLUSION 29 0.0021
594 POLLAKIURIA 88 0.0021
595 RHINITIS 17 0.0021
596 OSTEOARTHRITIS 89 0.0021
597 MYOCARDITIS 24 0.0021
598 BONE MARROW FAILURE 42 0.0021
599 MUSCLE ATROPHY 26 0.0021
600 EUPHORIC MOOD 21 0.0020
601 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0020
602 HIP ARTHROPLASTY 31 0.0020
603 HIATUS HERNIA 26 0.0020
604 UPPER LIMB FRACTURE 40 0.0020
605 FACIAL PARALYSIS 17 0.0020
606 HIP FRACTURE 64 0.0020
607 RESPIRATORY FAILURE 145 0.0020
608 MYALGIA 338 0.0020
609 CEREBRAL HAEMORRHAGE 71 0.0020
610 NOCTURIA 24 0.0020
611 DEPRESSED MOOD 104 0.0020
612 CEREBRAL INFARCTION 48 0.0020
613 IMMUNODEFICIENCY 29 0.0019
614 GAIT DISTURBANCE 372 0.0019
615 VENTRICULAR TACHYCARDIA 32 0.0019
616 COORDINATION ABNORMAL 27 0.0019
617 LEUKOCYTOSIS 35 0.0019
618 SKIN LESION 53 0.0019
619 HYPERTENSION 409 0.0019
620 OESOPHAGITIS 21 0.0019
621 FLANK PAIN 18 0.0019
622 DYSPHAGIA 182 0.0019
623 BLOOD POTASSIUM INCREASED 31 0.0019
624 VERTIGO 116 0.0019
625 DENTAL CARIES 21 0.0019
626 ORTHOSTATIC HYPOTENSION 33 0.0019
627 CONVULSION 108 0.0019
628 DIABETES MELLITUS INADEQUATE CONTROL 33 0.0019
629 BONE PAIN 109 0.0019
630 CHROMATURIA 42 0.0019
631 SKIN ULCER 48 0.0019
632 OEDEMA 100 0.0018
633 VENTRICULAR EXTRASYSTOLES 19 0.0018
634 OBESITY 29 0.0018
635 DIARRHOEA HAEMORRHAGIC 17 0.0018
636 PHOTOSENSITIVITY REACTION 30 0.0018
637 NEURALGIA 44 0.0018
638 DYSGEUSIA 134 0.0018
639 FACIAL PAIN 16 0.0018
640 HAEMARTHROSIS 16 0.0018
641 CONJUNCTIVITIS 33 0.0018
642 PHARYNGITIS 22 0.0018
643 MYOCARDIAL INFARCTION 309 0.0018
644 DERMATITIS 37 0.0018
645 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50 0.0018
646 ANGIOEDEMA 78 0.0018
647 PRESCRIBED OVERDOSE 34 0.0018
648 ABDOMINAL PAIN 407 0.0017
649 DERMATITIS ALLERGIC 22 0.0017
650 GASTRITIS 46 0.0017
651 GASTROINTESTINAL DISORDER 156 0.0017
652 RASH PAPULAR 39 0.0017
653 SEPSIS 193 0.0017
654 HYPOTHYROIDISM 55 0.0017
655 DYSURIA 63 0.0017
656 C-REACTIVE PROTEIN INCREASED 61 0.0017
657 AFFECT LABILITY 16 0.0017
658 DEHYDRATION 220 0.0016
659 NIGHTMARE 57 0.0016
660 VOMITING 774 0.0016
661 CARPAL TUNNEL SYNDROME 23 0.0016
662 STAPHYLOCOCCAL INFECTION 54 0.0016
663 PRODUCT TASTE ABNORMAL 22 0.0016
664 NERVE INJURY 18 0.0016
665 BACTERIAL INFECTION 30 0.0016
666 HAEMOGLOBIN DECREASED 165 0.0016
667 ANGINA PECTORIS 46 0.0016
668 ASTHENIA 602 0.0016
669 LABORATORY TEST ABNORMAL 47 0.0016
670 DISORIENTATION 63 0.0016
671 SKIN DISORDER 53 0.0016
672 EMPHYSEMA 16 0.0016
673 DELIRIUM 55 0.0016
674 MENTAL STATUS CHANGES 44 0.0016
675 DIARRHOEA 1021 0.0016
676 HYPOXIA 55 0.0016
677 GOUT 28 0.0016
678 FEBRILE NEUTROPENIA 103 0.0016
679 BLOOD SODIUM DECREASED 29 0.0015
680 SUBDURAL HAEMATOMA 22 0.0015
681 SEXUAL DYSFUNCTION 18 0.0015
682 HYPERTENSIVE CRISIS 17 0.0015
683 BRADYCARDIA 81 0.0015
684 PULMONARY ARTERIAL HYPERTENSION 22 0.0015
685 OEDEMA PERIPHERAL 185 0.0015
686 HYPOKINESIA 22 0.0015
687 TYPE 2 DIABETES MELLITUS 51 0.0015
688 TOXIC EPIDERMAL NECROLYSIS 23 0.0015
689 CARDIAC ARREST 125 0.0015
690 THIRST 27 0.0015
691 DRUG DISPENSING ERROR 23 0.0015
692 CARDIOMYOPATHY 22 0.0015
693 DYSARTHRIA 56 0.0015
694 ORAL HERPES 29 0.0015
695 NEOPLASM 17 0.0015
696 DRUG INTOLERANCE 142 0.0015
697 PARALYSIS 21 0.0015
698 HAEMATOMA 38 0.0015
699 CARDIOGENIC SHOCK 21 0.0015
700 CARDIO-RESPIRATORY ARREST 61 0.0015
701 FEMUR FRACTURE 45 0.0015
702 VISUAL ACUITY REDUCED 48 0.0014
703 IMMUNE SYSTEM DISORDER 19 0.0014
704 INSOMNIA 383 0.0014
705 HYPOMAGNESAEMIA 20 0.0014
706 COGNITIVE DISORDER 67 0.0014
707 SLEEP DISORDER 101 0.0014
708 WEIGHT DECREASED 399 0.0014
709 FEAR 38 0.0014
710 DISTURBANCE IN ATTENTION 76 0.0014
711 ACUTE RESPIRATORY FAILURE 27 0.0014
712 PRODUCT USE COMPLAINT 22 0.0014
713 ARRHYTHMIA 66 0.0014
714 TASTE DISORDER 28 0.0014
715 HERPES ZOSTER 79 0.0014
716 FLUID OVERLOAD 20 0.0014
717 BEDRIDDEN 18 0.0014
718 GASTROOESOPHAGEAL REFLUX DISEASE 110 0.0014
719 NIGHT SWEATS 44 0.0014
720 DEPRESSED LEVEL OF CONSCIOUSNESS 54 0.0014
721 MELAENA 30 0.0014
722 WEIGHT INCREASED 305 0.0014
723 HAEMATOCRIT DECREASED 27 0.0014
724 CIRCULATORY COLLAPSE 23 0.0013
725 RASH 586 0.0013
726 HAEMATEMESIS 34 0.0013
727 SUICIDE ATTEMPT 81 0.0013
728 NAUSEA 1056 0.0013
729 HYPOCALCAEMIA 25 0.0013
730 DEVICE RELATED INFECTION 20 0.0013
731 PRURITUS GENERALISED 28 0.0013
732 ABDOMINAL DISTENSION 135 0.0013
733 TENDONITIS 20 0.0013
734 MOUTH ULCERATION 27 0.0013
735 MUSCULAR WEAKNESS 141 0.0012
736 PNEUMONIA 400 0.0012
737 BACK PAIN 285 0.0012
738 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 64 0.0012
739 CONFUSIONAL STATE 198 0.0012
740 DEAFNESS 32 0.0012
741 MUSCULOSKELETAL DISCOMFORT 21 0.0012
742 RASH PRURITIC 66 0.0012
743 COLON CANCER 18 0.0012
744 GYNAECOMASTIA 37 0.0012
745 APHASIA 36 0.0012
746 PULMONARY EMBOLISM 112 0.0012
747 ANOSMIA 17 0.0012
748 AMNESIA 76 0.0012
749 SWELLING FACE 76 0.0012
750 FATIGUE 906 0.0012
751 TACHYCARDIA 103 0.0012
752 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
753 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
754 DRUG ABUSE 95 0.0011
755 ADVERSE EVENT 105 0.0011
756 HYPOGLYCAEMIA 55 0.0011
757 HALLUCINATION, AUDITORY 18 0.0011
758 RASH ERYTHEMATOUS 54 0.0011
759 PANIC ATTACK 41 0.0011
760 SENSORY DISTURBANCE 18 0.0011
761 RESTLESSNESS 41 0.0011
762 DYSPNOEA EXERTIONAL 42 0.0011
763 RESPIRATORY TRACT INFECTION 29 0.0011
764 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
765 SYNCOPE 111 0.0011
766 BLOOD URINE PRESENT 21 0.0011
767 HYPOPHAGIA 28 0.0011
768 LETHARGY 63 0.0011
769 DEEP VEIN THROMBOSIS 71 0.0011
770 LOCAL SWELLING 19 0.0011
771 HEPATIC CANCER 26 0.0011
772 PLATELET COUNT DECREASED 115 0.0011
773 INTENTIONAL PRODUCT USE ISSUE 94 0.0011
774 ULCER 17 0.0011
775 SKIN DISCOLOURATION 49 0.0011
776 CARDIOVASCULAR DISORDER 27 0.0011
777 PERITONITIS 22 0.0011
778 ALTERED STATE OF CONSCIOUSNESS 23 0.0011
779 ABNORMAL BEHAVIOUR 42 0.0011
780 HYPOTENSION 212 0.0011
781 THROMBOSIS 85 0.0011
782 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
783 OSTEOMYELITIS 19 0.0010
784 CHILLS 122 0.0010
785 PNEUMONIA ASPIRATION 26 0.0010
786 MENTAL IMPAIRMENT 25 0.0010
787 DISEASE RECURRENCE 49 0.0010
788 COLITIS 39 0.0010
789 CHEST PAIN 190 0.0010
790 AGITATION 75 0.0010
791 LUNG DISORDER 50 0.0010
792 CYANOSIS 16 0.0010
793 DRUG ADMINISTRATION ERROR 31 0.0010
794 MEDICATION ERROR 56 0.0010
795 WHITE BLOOD CELL COUNT DECREASED 109 0.0010
796 EYE DISORDER 33 0.0010
797 MUSCULOSKELETAL DISORDER 19 0.0010
798 CONDITION AGGRAVATED 303 0.0010
799 PERICARDIAL EFFUSION 23 0.0010
800 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
801 GLAUCOMA 19 0.0010
802 PRURITUS 378 0.0010
803 OVERDOSE 212 0.0010
804 BODY TEMPERATURE INCREASED 20 0.0010
805 HAEMORRHOIDS 19 0.0010
806 HYPERSENSITIVITY 180 0.0010
807 KIDNEY INFECTION 19 0.0010
808 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
809 CEREBROVASCULAR ACCIDENT 163 0.0010
810 ACCIDENTAL OVERDOSE 35 0.0010
811 ROAD TRAFFIC ACCIDENT 40 0.0010
812 DYSPEPSIA 94 0.0010
813 ISCHAEMIC STROKE 17 0.0010
814 GALLBLADDER DISORDER 17 0.0010
815 MOVEMENT DISORDER 30 0.0009
816 DECREASED APPETITE 217 0.0009
817 CARDIAC FAILURE 75 0.0009
818 IRRITABILITY 56 0.0009
819 INFLAMMATION 48 0.0009
820 LUNG NEOPLASM MALIGNANT 38 0.0009
821 SOMNOLENCE 185 0.0009
822 MOOD ALTERED 25 0.0009
823 GASTROINTESTINAL HAEMORRHAGE 76 0.0009
824 PARAESTHESIA 143 0.0009
825 SKIN EXFOLIATION 76 0.0009
826 HEADACHE 564 0.0009
827 EATING DISORDER 19 0.0009
828 MALAISE 391 0.0009
829 BLOOD PRESSURE DECREASED 59 0.0009
830 PLEURAL EFFUSION 54 0.0009
831 ANGER 30 0.0009
832 AGEUSIA 22 0.0009
833 WRONG TECHNIQUE IN DRUG USAGE PROCESS 32 0.0009
834 HAEMORRHAGE 92 0.0009
835 FAECES DISCOLOURED 19 0.0009
836 PRODUCT USE IN UNAPPROVED INDICATION 217 0.0009
837 CELLULITIS 44 0.0009
838 VIRAL INFECTION 29 0.0009
839 RESPIRATORY DISORDER 26 0.0009
840 NO ADVERSE EVENT 157 0.0009
841 INFLUENZA LIKE ILLNESS 71 0.0009
842 NEUTROPHIL COUNT DECREASED 35 0.0009
843 RASH MACULAR 30 0.0009
844 URINARY TRACT INFECTION 146 0.0009
845 HYPOAESTHESIA 128 0.0009
846 IMPAIRED HEALING 28 0.0009
847 SEIZURE 98 0.0008
848 DYSPNOEA 480 0.0008
849 HOSPITALISATION 130 0.0008
850 SPEECH DISORDER 44 0.0008
851 COVID-19 147 0.0008
852 HYPERHIDROSIS 107 0.0008
853 DEATH 714 0.0008
854 PULMONARY OEDEMA 37 0.0008
855 PAIN IN EXTREMITY 242 0.0008
856 OFF LABEL USE 717 0.0008
857 ARTHRALGIA 339 0.0008
858 UNRESPONSIVE TO STIMULI 21 0.0008
859 ABDOMINAL PAIN UPPER 167 0.0008
860 PALLOR 22 0.0008
861 SEDATION 21 0.0008
862 PRODUCTIVE COUGH 38 0.0008
863 NEOPLASM MALIGNANT 53 0.0008
864 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
865 BLISTER 44 0.0008
866 PRESYNCOPE 19 0.0008
867 GAIT INABILITY 26 0.0008
868 PALPITATIONS 91 0.0008
869 RED BLOOD CELL COUNT DECREASED 22 0.0008
870 HYPERSOMNIA 22 0.0008
871 DIZZINESS 382 0.0008
872 DYSKINESIA 31 0.0008
873 LIP SWELLING 25 0.0007
874 DIABETIC KETOACIDOSIS 18 0.0007
875 INFECTION 108 0.0007
876 RECTAL HAEMORRHAGE 32 0.0007
877 MUSCULOSKELETAL PAIN 39 0.0007
878 STOMATITIS 45 0.0007
879 TINNITUS 34 0.0007
880 ERYTHEMA 152 0.0007
881 AGGRESSION 37 0.0007
882 WITHDRAWAL SYNDROME 31 0.0007
883 COUGH 206 0.0007
884 THERAPY NON-RESPONDER 33 0.0007
885 ABASIA 18 0.0007
886 INJURY 51 0.0007
887 FUNGAL INFECTION 24 0.0007
888 LOSS OF CONSCIOUSNESS 92 0.0007
889 URTICARIA 120 0.0007
890 BRONCHITIS 53 0.0007
891 OXYGEN SATURATION DECREASED 40 0.0007
892 MUSCULOSKELETAL STIFFNESS 62 0.0007
893 INTERSTITIAL LUNG DISEASE 34 0.0007
894 INJECTION SITE REACTION 48 0.0007
895 URINARY RETENTION 23 0.0007
896 RESPIRATORY ARREST 19 0.0007
897 CRYING 25 0.0007
898 BLINDNESS 28 0.0007
899 CARDIAC FAILURE CONGESTIVE 55 0.0007
900 ASTHMA 76 0.0007
901 COMPLETED SUICIDE 56 0.0007
902 GASTRIC DISORDER 23 0.0007
903 OROPHARYNGEAL PAIN 62 0.0007
904 TREMOR 111 0.0007
905 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
906 BLOOD POTASSIUM DECREASED 20 0.0007
907 HALLUCINATION 50 0.0007
908 FLATULENCE 37 0.0007
909 ARTHRITIS 51 0.0006
910 ADVERSE DRUG REACTION 58 0.0006
911 DISCOMFORT 39 0.0006
912 MEMORY IMPAIRMENT 87 0.0006
913 ABDOMINAL PAIN LOWER 16 0.0006
914 NECK PAIN 35 0.0006
915 BALANCE DISORDER 53 0.0006
916 HAEMOPTYSIS 17 0.0006
917 BLOOD GLUCOSE INCREASED 114 0.0006
918 DRY MOUTH 49 0.0006
919 UNEVALUABLE EVENT 45 0.0006
920 THERAPEUTIC RESPONSE DECREASED 36 0.0006
921 CARDIAC DISORDER 55 0.0006
922 NEOPLASM PROGRESSION 20 0.0006
923 EPISTAXIS 43 0.0006
924 FEELING COLD 16 0.0006
925 FEELING HOT 35 0.0006
926 PRODUCT DOSE OMISSION 36 0.0006
927 INFLUENZA 61 0.0005
928 INTENTIONAL OVERDOSE 35 0.0005
929 FALL 181 0.0005
930 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
931 SINUSITIS 54 0.0005
932 ABDOMINAL DISCOMFORT 88 0.0005
933 SKIN IRRITATION 24 0.0005
934 ARTHROPATHY 29 0.0005
935 ACNE 39 0.0005
936 MUSCLE SPASMS 94 0.0005
937 HAEMATOCHEZIA 28 0.0005
938 OCULAR HYPERAEMIA 24 0.0005
939 DRUG DOSE OMISSION 83 0.0005
940 PRODUCT USE ISSUE 93 0.0005
941 ATRIAL FIBRILLATION 47 0.0005
942 CHEST DISCOMFORT 49 0.0005
943 ILL-DEFINED DISORDER 29 0.0005
944 ALOPECIA 92 0.0005
945 THERAPY CESSATION 24 0.0005
946 INCORRECT DOSE ADMINISTERED 106 0.0005
947 DRUG INEFFECTIVE 603 0.0005
948 FLUID RETENTION 23 0.0005
949 BURNING SENSATION 31 0.0004
950 CONSTIPATION 96 0.0004
951 MIGRAINE 42 0.0004
952 VISION BLURRED 60 0.0004
953 DRY SKIN 58 0.0004
954 DRUG WITHDRAWAL SYNDROME 38 0.0004
955 DYSPHONIA 25 0.0004
956 SWELLING 40 0.0004
957 INTENTIONAL PRODUCT MISUSE 37 0.0004
958 WHEEZING 25 0.0004
959 VISUAL IMPAIRMENT 52 0.0004
960 FEELING ABNORMAL 98 0.0004
961 NASAL CONGESTION 23 0.0004
962 EYE PAIN 22 0.0004
963 DRUG EFFECT DECREASED 21 0.0004
964 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
965 NERVOUSNESS 20 0.0004
966 PERIPHERAL SWELLING 58 0.0004
967 PROSTATE CANCER 30 0.0004
968 BLOOD PRESSURE INCREASED 55 0.0004
969 CATARACT 21 0.0004
970 DISEASE PROGRESSION 41 0.0003
971 JOINT SWELLING 41 0.0003
972 NASOPHARYNGITIS 62 0.0003
973 SURGERY 19 0.0003
974 HEART RATE INCREASED 32 0.0003
975 CONTUSION 30 0.0003
976 ILLNESS 31 0.0003
977 EYE IRRITATION 17 0.0003
978 SKIN BURNING SENSATION 21 0.0003
979 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
980 HOT FLUSH 22 0.0003
981 RHINORRHOEA 18 0.0003
982 FLUSHING 28 0.0003
983 UNDERDOSE 20 0.0003
984 DRUG DEPENDENCE 41 0.0003
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
986 PRODUCT QUALITY ISSUE 34 0.0003
987 PSORIASIS 27 0.0002
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
989 PRODUCT DOSE OMISSION ISSUE 40 0.0001
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
991 INJECTION SITE PAIN 26 0.0001